U.S. Food And Drug Administration (FDA)

Showing 41-48 of 48 results

Research roundup: November 2019 edition

The ACOG Committee Opinion’s support for over-the-counter hormonal contraception, efficacy of intracervical blocks for pain management during levonorgestrel IUD placement, studies on the mechanism of function of ulipristal acetate, and more.

How to help people get the emergency contraception (EC) pills they need

Barriers to accessing EC pills exist, what are they and how can you help people get the EC pills they need.

Exciting News—LILETTA now approved for use up to 8 years!

The FDA has extended approval of LILETTA IUDs for up to 6 years of use, research shows they are safe and effective for up to 7 years.

Research roundup: September 2019 edition

An analysis of the efficacy and safety of telehealth medication abortion care, IUD use and a decreased risk of ovarian cancer, widespread support for HPV vaccination, and more.

Talking fertility awareness methods with your patients

You may have your doubts about FAM, but what if your patients want to use it?

What makes the Liletta IUD different from Mirena?

Here’s what you and your patients should know about these two (very similar) hormonal IUDs.

Starting birth control after using ‘ella’ for EC

Here’s what you need to know to help your patients balance risks and uncertainties related to starting hormonal birth control after ella.

Hello, Skyla! Getting to know the newest IUD

A new IUD option hits the U.S. market—and it’s (officially) for ladies without kids.
  • Previous
  • 2
  • 3
  • 4
  • 5
  • 6(current)
  • Next